Genetic alterations of chromosome 7 are common in human cancer. Furthermore
, previous studies have supported the presence of a gene important in a bro
ad range of cancers at 7q22-31.1, There is evidence that supports an oncoge
nic function for this putative gene, as well as evidence that supports a tu
mor suppressive role. In this study, we used a cross-species candidate gene
approach in combination with physical mapping to identify MPP11 as a candi
date for the putative cancer-related activity at 7q22-31.1. We then analyze
d primary head and neck squamous cell tumors (HNSCCs) for loss of heterozyg
osity/allelic imbalance (LOH/AI) at the MPP11 genomic locus. Thirty-eight p
ercent of tumors examined displayed LOH/AI involving the MPP11 genomic locu
s. Mutation analysis of MPP11 in the latter samples did not identify any in
activating mutations, However, immunohistochemical staining of primary tumo
r sections and Western blot analysis of HNSCC cell lines revealed a tumor-s
pecific high level of expression of MPP11p, Fluorescence in situ hybridizat
ion analysis done on the cell lines identified increased chromosome 7 copy
number with a concomitant increase in MPP11 copy number. These results sugg
est an oncogenic role for MPP11 in HNSCC.